IRADIMED CORPORATION (IRMD) Guidance & Earnings Results
On 2026-05-01 IRADIMED CORPORATION reaffirmed guidance: "FY2026 revenue $91M-$96M, GAAP EPS $1.90-$2.05, non-GAAP EPS…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRMDIRADIMED CORPORATIONFollow IRMD — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- 47.9
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 29 Oct, in 4 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 1 May 26 | Reaffirmed | FY2026 revenue $91M-$96M, GAAP EPS $1.90-$2.05, non-GAAP EPS $2.06-$2.21 · full year |
| 10 Feb 26 | Raised | FY2026 revenue $91-96M; GAAP diluted EPS $1.90-2.05; non-GAAP diluted EPS $2.06-2.21 · full year |
| 3 Nov 25 | Raised | FY2025 revenue guidance raised to $82.5M-$83.5M; GAAP EPS to $1.68-$1.72 · full year |
| 1 Aug 25 | Raised | FY2025 revenue raised to $80.0-82.5M from $78.0-82.0M; GAAP EPS raised to $1.60-1.70 from $1.55-1.65; non-GAAP EPS raised to $1.76-1.86 from $1.71-1.81; Q3 2025 revenue $20.5-20.9M; Q3 GAAP EPS $0.41-0.45; Q3 non-GAAP EPS $0.45-0.49 · full year |
IRADIMED CORPORATION — questions
- What guidance did IRADIMED CORPORATION give?
- On 2026-05-01: "FY2026 revenue $91M-$96M, GAAP EPS $1.90-$2.05, non-GAAP EPS $2.06-$2.21"
- When does IRADIMED CORPORATION report earnings?
- IRADIMED CORPORATION's next earnings report is expected on 2026-10-29.
Every figure on this page comes from IRADIMED CORPORATION's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.